Pillstats
Rx only · Capsule · Oral

Omega-3-Acid Ethyl Esters

Brands: Lovaza · Omega-3-Acid Ethyl Esters

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)484348
US makers6 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.050$0.099$0.149$0.198Dec 2025Apr 2026Jul 2026
$0.172
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.1K12K18K25K2025 Q12025 Q22025 Q32025 Q42026 Q1
16K
Rx · 2026 Q1
2.2M
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Strides Pharma Science Limitedunknown2SUPPLYING
KD Pharma USA, Inc.unknown2SUPPLYING
Waylis Therapeutics LLCunknown1SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Par Pharmaceutical Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.